Sepsis threatens the lives of over 27 million people each year worldwide. Inappropriate or delayed treatment allows for disease progression to severe sepsis, septic shock and ultimately to 8 million deaths per year.
Recent efforts to reduce mortality have focused on generating definitions of sepsis and related conditions and establishing guidelines for early identification and implementation of goal-directed (individualized) therapy. Despite this, the incidence of sepsis has increased significantly in the US with hospitalizations and related costs doubling over the last 10 years.
Rapid diagnosis of sepsis is paramount to reduce mortality. This webinar will summarize current guidelines for sepsis diagnosis and management with a focus on the role of laboratory testing including lactate.
It will discuss the utility of lactate in both diagnosis and monitoring of sepsis, including the pre-analytical and analytical requirements for accurate testing. The webinar will also include a brief discussion of the most promising emerging biomarkers and diagnostic strategies in sepsis.
This webinar will:
- Outline the most recent definitions and guidelines for monitoring sepsis.
- Assess the role of the laboratory testing in the diagnosis and monitoring of sepsis.
- Discuss the importance of accurate lactate testing in the septic patient.
- Review novel approached to diagnosis and treatment of sepsis.
Alison Woodworth, PhD, DABCC, FACB, Associate Professor of Pathology and Laboratory Medicine, University of Kentucky Medical Center
Who Should Attend?
- Point-of-care coordinators
- Respiratory therapists
- One PACE® credit-hour will be provided for this session.
- This session is approved for 1 Florida CE credit.
- Florida Board of Clinical Laboratory Personnel approved number: 50-12563
- Application has been made to the American Association for Respiratory Care (AARC) for continuing education contact hours for respiratory therapists